We are live on
!
Find out more
PG
Proffitt & Goodson Portfolio holdings
AUM
$728M
1-Year Est. Return
18.62%
This Fund
S&P 500
This Quarter
Est. Return
+0.36%
1 Year Est. Return
+18.62%
3 Year Est. Return
+48.49%
5 Year Est. Return
+42.28%
10 Year Est. Return
+158.21%
AUM
$175M
AUM Growth
+$5.04M
(+3%)
Cap. Flow
+$4.04M
Cap. Flow
% of AUM
2.31%
Top 10 Holdings %
Top 10 Hldgs %
78.82%
Holding
45
New
4
Increased
30
Reduced
9
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$1.21M |
| 2 |
Bank of America
BAC
|
+$1.13M |
| 3 |
Leidos
LDOS
|
+$1M |
| 4 |
Apple
AAPL
|
+$509K |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$394K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.19M |
| 2 |
ConocoPhillips
COP
|
+$972K |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$487K |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$66K |
| 5 |
AT&T
T
|
+$18K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.91% |
| 2 | Technology | 5.03% |
| 3 | Healthcare | 3% |
| 4 | Industrials | 2.93% |
| 5 | Consumer Staples | 2.8% |
Similar funds
VU
ITC
CIAM
IP
LOAMU
CCP
KF
IA
Proffitt & Goodson's Q1 2016 Portfolio in Review
As of Q1 2016, Proffitt & Goodson held 45 positions worth $175M, up 3% from $170M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Proffitt & Goodson's Q1 2016 filing shows 4 new, 30 increased, 9 reduced and 2 closed positions. Its largest new stake was iShares Biotechnology ETF: 13,560 shares worth $1.18M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $1.19M.
By sector, the portfolio is most concentrated in Miscellaneous at 80% of assets, down from 82% a quarter earlier, followed by Technology and Healthcare.
- Proffitt & Goodson's largest Q1 2016 buy was iShares Biotechnology ETF: 13,560 shares worth $1.18M.
- Proffitt & Goodson added most to Bank of America in Q1 2016, an estimated $1.13M increase.
- Proffitt & Goodson's biggest Q1 2016 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $487K.
- Proffitt & Goodson fully exited State Street SPDR S&P Biotech ETF in Q1 2016, selling an estimated $1.19M.
- Proffitt & Goodson's ten largest holdings make up 79% of its $175M portfolio in Q1 2016.
- Proffitt & Goodson opened 4 new positions and closed 2 in Q1 2016.
- Proffitt & Goodson's portfolio value rose 3% quarter-over-quarter to $175M.
Based on Proffitt & Goodson's 13F filing for Q1 2016, filed 19 Apr 2016.